Lack of association of DMB polymorphism with insulin-dependent diabetes

Journal of Autoimmunity

Volumn 10, Issue 4, 1997, Pages 395-400

  Esposito, Laura ^a   Lampasona, Vito ^a   Bonifacio, Ezio ^b   Bosi, Emanuele ^b   Ferrari, Maurizio ^a  

^a Dept Lab Med Ist Sci S R ^*  (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Disequilibrium; DMB; Insulin dependent diabetes mellitus; Linkage; TAP peptide transporter gene HLA class II

Indexed keywords

ADULT; ALLELE; ARTICLE; DNA POLYMORPHISM; FEMALE; GENETIC RISK; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; IMMUNOGENETICS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0031214658     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0144     Document Type: Article

References (37)

1. Todd J.A. The role of MHC class II genes in type I diabetes. Curr. Top. Microb. Imm. 164:1990;17-40.
2. Sterkers G., Zeliszewski D., Chausée A.M., Deschamps I., Font M.P., Freidel C., Hors J., Betuel H., Dausset J., Levy J.P. HLA-DQ rather than HLA-DR region might be involved in dominant non-susceptibility to diabetes. Proc. Natl. Acad. Sci. USA. 85:1988;6473-6477.
3. Todd J.A., Bell J.I., McDevitt H.O. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 329:1987;599-604.
4. Morel P.A., Dorman J.S., Todd J.A., McDevitt H.O., Trucco M. Aspartic acid at position 57 of the HLA-DQβ chain protects against type I diabetes: a family study. Proc. Natl. Acad. Sci. USA. 85:1988;8111-8115.
5. Dorman J.S., LaPorte R.E., Stone R.A., Trucco M. World-wide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQβ chain. Proc. Natl. Acad. Sci. USA. 87:1990;7370-7374.
6. Khalil H., d'Auriol L., Gobet M., Morin L., Lepage V., Deschamps I., Park M.S., Degos L., Galibert F., Hors J. A combination of HLA-DQβ Asp 57 negative and HLA-DQα Arg 52 confers susceptibility to insulin-dependent diabetes mellitus. J. Clin. Invest. 85:1990;1315-1319.
7. Baish J.M., Weeks T., Giles R., Hoover M., Stastny P., Capra D. Analysis of HLA DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N. Engl. J. Med. 322:1990;1836-1846.
8. Kaufman J.F., Auffray C., Korman A.J., Shackelford D.A., Strominger J.L. The class II molecules of human and murine major histocompatibility complex. Cell. 36:1984;1-13.
9. Todd J.A., Acha-Orbea H., Bell J.I., Chao N., Fronek Z., Jacob C.O., McDermott M., Sinha A.A., Timmerman L., Steinman L., McDevitt H.O. A molecular basis for MHC class II-associated autoimmunity. Science. 240:1988;1003-1009.
10. Campbell R.D., Trowsdale J. Map of the human major histocompatibility complex. Immunol. Today. 14:1993;349-352.
11. Beck S., Kelly A., Radley E., Khurshid F., Alderton R.P., Trowsdale J. DNA sequence analysis of 66 kb of the human MHC class II region encoding a cluster of genes for antigen processing. J. Mol. Biol. 228:1992;433-441.
12. Deverson E.V., Gow I.R., Coadwell J., Monaco J.J., Butcher G.W., Howard J.C. MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature. 348:1990;738-741.
13. Trowsdale J., Hanson I., Mockridge I., Beck S., Townsend A., Kelly A. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature. 348:1990;741-744.
14. Spies T., Bresnahan M., Bahram S., Arnold D., Blanck G., Mellins E., Pious D., DeMars R. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature. 348:1990;744-747.
15. Caillat-Zucman S., Bertin E., Timsit J., Boitard C., Assan R., Bach J.F. Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene. Eur. J. Immunol. 23:1993;1784-1788.
16. Martinez-Laso J., Martin-Villa J.M., Alvarez M., Martinez-Quiles N., Lledo G., Arnaiz-Villena A. Susceptibility to insulin-dependent diabetes mellitus and short cytoplasmic ATP-binding domain TAP2*01 alleles. Tissue Antigens. 44:1994;184-188.
17. Rønningen K.S., Undlien D.E., Ploski R., Maouni N., Konrad R.J., Jensen E., Hornes E., Reijonen H., Colonna M., Monos D.S., Strominger J.L., Thorsby E. Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin-dependent diabetes mellitus. Eur. J. Immunol. 23:1993;1050-1056.
18. Cucca F., Congia M., Trowsdale J., Powis S.H. Insulin-dependent diabetes mellitus and the major histocompatibility complex peptide transporters TAP1 and TAP2: no association in a population with a high disease incidence. Tissue Antigens. 44:1994;234-240.
19. Esposito L., Lampasona V., Bosi E., Poli F., Ferrari M., Bonifacio E. HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: no evidence for an additional contribution to disease risk by the TAP2 locus. Diabetologia. 38:1995;968-974.
20. Lehner P.J., Cresswell P. Processing and delivery of peptides presented by MHC class I molecules. Curr. Opin. Immunol. 8:1996;59-67.
21. Deng G.Y., Muir A., Maclaren N.K., She J.X. Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies. Am. J. Hum. Genet. 56:1995;528-534.
22. Undlien D.E., Akselsen H.E., Joner G., Dahl-Jørgensen K., Søvik O., Rønningen K.S., Thorsby E. No independent associations of LMP2 and LMP7 polymorphisms with susceptibility to develop IDDM. Diabetes. 46:1997;307-312.
23. Kelly A.P., Monaco J.J., Cho S., Trowsdale J. A new human HLA class II-related locus, DM. Nature. 353:1991;571-573.
24. Cho S., Attaya M., Monaco J.J. New class II-like genes in the murine MHC. Nature. 353:1991;573-576.
25. Morris P., Shaman J., Attaya M., Amaya M., Goodman S., Bergman C., Monaco J.J., Mellins E. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature. 368:1994;551-554.
26. Fling S.P., Arp B., Pious D. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature. 368:1994;554-558.
27. Wolf P.R., Ploegh H.L. DM exchange mechanism. Nature. 376:1995;464-465.
28. Sanderson F., Powis S.H., Kelly A.P., Trowsdale J. Limited polymorphism in HLA-DM does not involve the peptide binding groove. Immunogenetics. 39:1994;56-58.
29. Carrington M., Yeager M., Mann D. Characterisation of HLA-DMB polymorphism. Immunogenetics. 38:1993;446-449.
30. Djilali-Saiah I., Benini V., Schmitz J., Timsit J., Assan R., Boitard C., Bach J.F., Caillat-Zucman S. Absence of primary association between DM gene polymorphism and insulin-dependent diabetes mellitus or celiac disease. Hum. Immunol. 49:1996;22-27.
31. Maniatis T.M., Fritsch E.F., Sambrook J. Molecular Cloning. A Laboratory Manual. 1982;Cold Spring Harbor Laboratory, New York.
32. Goldman D., Merril C.R. Silver staining of DNA in polyacrilamide gels: linearity and effect of fragment size. Electrophoresis. 3:1982;24-26.
33. Powis S.H., Tonks S., Mockridge I., Kelly A.P., Bodmer J.G., Trowsdale J. Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2. Immunogenetics. 37:1993;373-380.
34. Ott J. Analysis of Human Genetic Linkage. 1991;The Johns Hopkins University Press, Baltimore, London.
35. Arnheim N., Strange C., Herlich H. Use of pooled DNA samples to detect linkage disequilibrium of polymorphic restriction fragments and human disease: studies of the HLA class II loci. Proc. Natl. Acad. Sci. USA. 82:1985;6970-6974.
36. McGinnis R.E., Spielman R.S. Linkage disequilibrium in the insulin gene region: size variation at the 5′ flanking polymorphism and bimodality among "class I'' alleles. Am. J. Hum. Genet. 55:1994;526-532.
37. Carrington M., Stephens J.C., Klitz W., Begovich A.B., Erlich H.A., Mann D. Major histocompatibility complex class II haplotypes and linkage disequilibrium values observed in the CEPH families. Hum. Immunol. 41:1994;234-240.